Vaxess Technologies Funding: $55M Raised, Series B (2021)
Vaxess Technologies is based in Cambridge, Massachusetts. It has raised $55M in total funding. Latest round: Series B.
Vaxess Technologies funding overview
Vaxess Technologies is based in Cambridge, Massachusetts. Vaxess Technologies has raised $55M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in January 2021. The round record for Vaxess Technologies runs through 2021; nothing later has been disclosed. Investors on record include RA Capital Management, MIT's The Engine, Mission BioCapital, Global Health Investment Corporation. 4 distinct backers are named across the disclosed rounds.
Vaxess Technologies at a glance
Total raised
$55M
Latest round
Series B
Latest round date
January 2021
Headquarters
Cambridge, Massachusetts
Notable investors
RA Capital Management, MIT's The Engine, Mission BioCapital, Global Health Investment Corporation
Frequently asked about Vaxess Technologies funding
How much has Vaxess Technologies raised?
Vaxess Technologies has raised $55M in total disclosed funding across the rounds on record.
Who has invested in Vaxess Technologies?
RA Capital Management, MIT's The Engine, Mission BioCapital, Global Health Investment Corporation are named among the investors backing Vaxess Technologies.
What was the latest Vaxess Technologies funding round?
The most recent disclosed round is a Series B, announced in January 2021.
Where is Vaxess Technologies based?
Vaxess Technologies is based in Cambridge, Massachusetts.
When did Vaxess Technologies last raise?
The last disclosed Vaxess Technologies round closed in January 2021 at Series B.
Totals shown for Vaxess Technologies aggregate every disclosed round on file. To see how that compares, browse the companies in Cambridge and the investors behind them below.
